2023 annual financial data
Taysha Gene Therapies 2023 Operating margin
Taysha Gene Therapies 2023 operating margin with verified reported values.
Direct answer
Operating margin was -468.83%.
Operating income was -72,439,000 USD and net income was -111,566,000 USD.
Operating cash flow was -73,018,000 USD.
Get free Taysha Gene Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,451,000 USD
- Operating income
- -72,439,000 USD
- Net income
- -111,566,000 USD
- Operating cash flow
- -73,018,000 USD